The 68th Annual General Meeting of Dätwyler Holding Inc. was held in Altdorf on Tuesday, 17 March 2026. Shareholders approved all Board proposals by a large majority. A total of 30’246’838 votes or 87.42% of the total number of voting shares were represented.
Stable dividend thanks to solid free cash flow
The Annual General Meeting approved a stable dividend of CHF 3.20 per bearer share and CHF 0.64 per registered share. A solid free cash flow in the 2025 reporting year made it possible to further strengthen the balance sheet and keep the dividend payment stable. The dividend will be paid out free of charges from 23 March 2026. The first trading date without dividend entitlement (ex-date) is 19 March 2026.
At the Annual General Meeting, management reaffirmed its long-term commitment to the strategic development of the Group. Datwyler focuses on high-growth, regulated markets and creates sustainable value along its three core competencies – material expertise, solution design and industrial-scale manufacturing. In this context, the company continues to strengthen its business areas, most recently through the majority stake in Capsul’in in the Food & Beverage segment. Schattdorf acts as the most important production site in this business area and at the same time as the central innovation and technology hub of the Group.
Age-related changes to the Board of Directors
As previously announced, Gabi Huber and Jürg Fedier did not stand for re-election to the Board of Directors due to age-related reasons. Stephanie Bregy and Christian Holzgang were newly elected to the Board. Stephanie Bregy is Group General Counsel of SBB and previously held various international roles at Novartis. Christian Holzgang is CEO of the Amsonic-KKS Group and serves on the executive committees of the Swiss Employers’ Association and Swissmem. All other Directors were re-elected for a further one-year term. At the special meeting of the bearer shareholders, the current Board members Martin Hirzel and Dirk Lambrecht, as well as Britt Hendriksen, were re-elected as their representatives.
The Board of Directors continues to consist of nine members and remains chaired by Paul Hälg. Hanspeter Fässler (Chairman), Claude R. Cornaz, Jens Breu and Dirk Lambrecht were elected to the Nomination and Compensation Committee. The Audit Committee comprises Britt Hendriksen (Chairwomen), Martin Hirzel and Stephanie Bregy. Public shareholders are therefore represented by two members on the Audit Committee and by one member on the Nomination and Compensation Committee. KPMG was confirmed as the statutory auditor for a further one-year term.
We would like to express our sincere gratitude to Gabi Huber and Jürg Fedier for their many years of valuable service on the Datwyler Board and in the Audit Committee, and we wish them all the very best for the future. As a legal expert with an international background in the pharmaceutical industry, Stephanie Bregy will contribute valuable new expertise to the Board. With Christian Holzgang, we are gaining an industrial leader with strong ties to the Swiss Canton of Uri. Together with the existing members, I look forward to our future collaboration.
Chairman
Inquiries
Katharina Immoor
SVP Corporate Communications & Investor Relations
Further information
